Multi-center Registry for CCSVI Testing and Treatment

NCT ID: NCT01205633

Last Updated: 2012-09-18

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

SUSPENDED

Total Enrollment

1000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2010-09-30

Study Completion Date

2015-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Patients suspected of CCSVI (chronic cerebrospinal venous insufficiency) may be tested and if appropriate treated with catheter venoplasty by an interventional radiologist in their local community who has been credentialled either by the local hospital's IRB or a national IRB if the procedure is done in an outpatient facility. Catheter angioplasty is a long-established and accepted medical procedure, patients' insurance should but may not cover the testing or treatment.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

more to follow

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

CCSVI Chronic Cerebrospinal Venous Insufficiency Venous Malformations of CNS Draining Veins

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

neurodegenerative disease neurovascular disease fatigue Hubbard Foundation angioplasty

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

CNS draining vein abnormalities

venous angioplasty

Intervention Type PROCEDURE

catheter venous angioplasty via femoral vein approach

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

venous angioplasty

catheter venous angioplasty via femoral vein approach

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Referral by patients primary treating physician for suspected CCSVI

Exclusion Criteria

Abnormal kidney function Allergy to either or both of the imaging contrast agents Pacemaker or other implantable device Ferrous metal in or on the body Claustrophobia Pregnancy

\-
Minimum Eligible Age

18 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Hubbard Foundation

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

David R Hubbard, M.D.

Role: STUDY_CHAIR

Hubbard Foundation

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Vascular Access Center of Downey

Downey, California, United States

Site Status

North County Radiology

Oceanside, California, United States

Site Status

Vascular Access Care of Atlanta

Atlanta, Georgia, United States

Site Status

Columbia endovascular Associates

New York, New York, United States

Site Status

Valley Endovascular Associates

Poughkeepsie, New York, United States

Site Status

Dayton Interventional Radiology

Dayton, Ohio, United States

Site Status

Utah Valley Interventional Associates

Provo, Utah, United States

Site Status

Utah Vascular Clinic

Salt Lake City, Utah, United States

Site Status

Vascular Access Center of Seattle

Seattle, Washington, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Related Links

Access external resources that provide additional context or updates about the study.

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CCSVI Registry

Identifier Type: -

Identifier Source: org_study_id